Charmacy Pharmaceutical Co., Ltd. (HKG:2289)
5.81
0.00 (0.00%)
At close: Mar 27, 2026
Charmacy Pharmaceutical Revenue
In the year 2025, Charmacy Pharmaceutical had annual revenue of 4.38B CNY, down -1.15%. Charmacy Pharmaceutical had revenue of 2.16B in the half year ending June 30, 2025, a decrease of -5.02%.
Revenue
4.38B CNY
Revenue Growth
-1.15%
P/S Ratio
0.13
Revenue / Employee
5.16M CNY
Employees
849
Market Cap
627.48M HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 4.38B | -50.83M | -1.15% |
| Dec 31, 2024 | 4.44B | 31.83M | 0.72% |
| Dec 31, 2023 | 4.40B | 228.35M | 5.47% |
| Dec 31, 2022 | 4.18B | 381.66M | 10.06% |
| Dec 31, 2021 | 3.79B | -198.09M | -4.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sinopharm Group | 626.85B |
| Sipai Health Technology | 3.75B |
| ETHK Labs | 3.14B |
| Sinco Pharmaceuticals Holdings | 2.32B |
| ClouDr Group | 1.81B |
| 160 Health International | 725.41M |
| Ziyuanyuan Holdings Group | 575.61M |
| Wanjia Group Holdings | 163.70M |